(Source) Intestinal obstructions: One study found that participants who took an incretin-based drug (e.g, a GLP-1 like Ozempic) were over 4.5 times more likely to report having an intestinal obstruction than those taking other diabetes medications
The approval of the once-daily injection (18 mg/3 mL), as an adjunct to diet and exercise, is intended to help with drug shortages and improve patient access
The study reviewed patient data to evaluate long term neurological outcomes among individuals using GLP-1 medications for diabetes and weight loss
As your body adjusts to reduced caloric intake, changes in glucose metabolism, and shifts in hormone signaling, some users experience temporary or persistent fatigue
In AD, glutamatergic and cholinergic synapses of the temporal lobe are affected first, followed by a spread to other regions (Picconi et al., 2005